Pamela Moise

2.1k total citations
38 papers, 1.6k citations indexed

About

Pamela Moise is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Pamela Moise has authored 38 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 14 papers in Epidemiology and 14 papers in Clinical Biochemistry. Recurrent topics in Pamela Moise's work include Antimicrobial Resistance in Staphylococcus (21 papers), Bacterial Identification and Susceptibility Testing (14 papers) and Antibiotic Use and Resistance (10 papers). Pamela Moise is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (21 papers), Bacterial Identification and Susceptibility Testing (14 papers) and Antibiotic Use and Resistance (10 papers). Pamela Moise collaborates with scholars based in United States, Spain and Germany. Pamela Moise's co-authors include George Sakoulas, Jerome J. Schentag, Alan Forrest, Kenneth C. Lamp, Mary C. Birmingham, Maria Amodio-Groton, Michael R. Yeaman, Ellie Hershberger, Judith N. Steenbergen and Sujata M. Bhavnani and has published in prestigious journals such as Journal of the American Society of Nephrology, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Pamela Moise

36 papers receiving 1.6k citations

Peers

Countries citing papers authored by Pamela Moise

Since Specialization

Citations

This map shows the geographic impact of Pamela Moise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela Moise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela Moise more than expected).

Fields of papers citing papers by Pamela Moise

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela Moise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela Moise. The network helps show where Pamela Moise may publish in the future.

Co-authorship network of co-authors of Pamela Moise

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela Moise. A scholar is included among the top collaborators of Pamela Moise based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela Moise. Pamela Moise is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical events and healthcare resource utilization associated with neutropenia and leukopenia among adult kidney transplant recipients receiving valganciclovir 2025 ·World Journal of Transplantation ·A Beyer, Pamela Moise, Michael Wong, Wei Gao, (unknown), (unknown), Martha Pavlakis, Flavio Vincenti, (unknown)	0
2	Impact of kidney function on 200 days of antiviral prophylaxis for cytomegalovirus disease in cytomegalovirus-seronegative recipients of cytomegalovirus-seropositive donor kidneys: Post hoc analysis of a randomized, phase 3 trial of letermovir vs valganciclovir prophylaxis 2025 ·American Journal of Transplantation ·Klemens Budde, Nassim Kamar, Marta Crespo, Catherine B. Small, Nicole Stauffer, (unknown), Chantal Gilbert, Pamela Moise, Barbara Haber	1
3	Association of SARS-CoV-2 status and antibiotic-resistant bacteria with inadequate empiric therapy in hospitalized patients: a US multicenter cohort evaluation (July 2019 - October 2021) 2023 ·BMC Infectious Diseases ·Karri A. Bauer, Laura Puzniak, Kalvin Yu, Kenneth Klinker, (unknown), Pamela Moise, Lyn Finelli, Vikas Gupta	4
4	Morbidity and mortality of hospitalised patients with candidemia during the various severe acute respiratory syndrome coronavirus 2 pandemic waves: A multicentre evaluation of 248 US hospitals 2023 ·Mycoses ·Karri A. Bauer, Kalvin Yu, Pamela Moise, Lyn Finelli, (unknown), (unknown), Gang Ye, Vikas Gupta	6
5	Epidemiology and outcomes of culture-positive bloodstream pathogens prior to and during the SARS-CoV-2 pandemic: a multicenter evaluation 2022 ·BMC Infectious Diseases ·Karri A. Bauer, Laura Puzniak, Kalvin Yu, Lyn Finelli, Pamela Moise, (unknown), (unknown), Vikas Gupta	13
6	Ceftolozane-tazobactam activity against clinical isolates of Pseudomonas aeruginosa from ICU patients with pneumonia: United States, 2015–2018 2021 ·International Journal of Infectious Diseases ·Michael A. Pfaller, Dee Shortridge, (unknown), Mark W. Garrison, C Andrew DeRyke, Daryl D. DePestel, Pamela Moise, Hélio S. Sader	15
7	A multicenter analysis of the clinical microbiology and antimicrobial usage in hospitalized patients in the US with or without COVID-19 2021 ·BMC Infectious Diseases ·Laura Puzniak, Lyn Finelli, Kalvin Yu, Karri A. Bauer, Pamela Moise, Carisa De Anda, (unknown), (unknown), Vikas Gupta	23
8	Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation 2015 ·Clinical Therapeutics ·Pamela Moise, (unknown), Annie Wong‐Beringer, (unknown), Kenneth C. Lamp, Winter J. Smith, Karri A. Bauer, Debra A. Goff, (unknown), Kimberly Leuthner, (unknown), James A. McKinnell, (unknown), (unknown), Thomas P. Lodise, Luis Felipe Reyes, Marcus Zervos	50
9	Antimicrobial Salvage Therapy for Persistent Staphylococcal Bacteremia Using Daptomycin Plus Ceftaroline 2014 ·Clinical Therapeutics ·George Sakoulas, Pamela Moise, Anthony M. Casapao, Poochit Nonejuie, Joshua Olson, Cheryl Okumura, Michael J. Rybak, Ravina Kullar, Abhay Dhand, Warren E. Rose, Debra A. Goff, Adam Bressler, (unknown), Joseph Pogliano, Scott Johns, Glenn W. Kaatz, John R. Ebright, Victor Nizet	139
10	Reduced Susceptibility to Host-Defense Cationic Peptides and Daptomycin Coemerge in Methicillin-Resistant Staphylococcus aureus From Daptomycin-Naive Bacteremic Patients 2012 ·The Journal of Infectious Diseases ·Nagendra N. Mishra, (unknown), Pamela Moise, Michael R. Yeaman, George Sakoulas	48
11	Retrospective Observational Study Comparing Vancomycin Versus Daptomycin as Initial Therapy for Staphylococcus aureus Infections 2011 ·Clinical Therapeutics ·(unknown), Pamela Moise, (unknown)	10
12	Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions 2009 ·The Lancet Infectious Diseases ·Pamela Moise, Donald S. North, Judith N. Steenbergen, George Sakoulas	93
13	Genotypic and phenotypic relationships among methicillin-resistant Staphylococcus aureus from three multicentre bacteraemia studies 2009 ·Journal of Antimicrobial Chemotherapy ·Pamela Moise, Davida S. Smyth, D. Ashley Robinson, (unknown), (unknown), George Sakoulas	21
14	Factors Influencing Time to Vancomycin‐Induced Clearance of Nonendocarditis Methicillin‐ResistantStaphylococcus aureusBacteremia: Role of Platelet Microbicidal Protein Killing andagrGenotypes 2009 ·The Journal of Infectious Diseases ·Pamela Moise, Alan Forrest, Arnold S. Bayer, Yan Q. Xiong, Michael R. Yeaman, George Sakoulas	24
15	Microbiological effects of prior vancomycin use in patients with methicillin-resistant Staphylococcus aureus bacteraemia 2007 ·Journal of Antimicrobial Chemotherapy ·Pamela Moise, Davida S. Smyth, (unknown), D. Ashley Robinson, Patricia N. Holden, Alan Forrest, George Sakoulas	96
16	Clinical Experience With Linezolid in Conjunction With Wound Coverage Techniques for Skin and Soft-Tissue Infections and Postoperative Osteomyelitis 2004 ·Annals of Plastic Surgery ·Kevin Broder, Pamela Moise, (unknown), Alan Forrest, Jerome J. Schentag	12
17	The efficacy and safety of linezolid as treatment for Staphylococcus aureus infections in compassionate use patients who are intolerant of, or who have failed to respond to, vancomycin 2002 ·Journal of Antimicrobial Chemotherapy ·Pamela Moise	69
18	Vancomycin treatment failures in Staphylococcus aureus lower respiratory tract infections 2000 ·International Journal of Antimicrobial Agents ·Pamela Moise, Jerome J. Schentag	90
19	Pharmacokinetics and metabolism of moxifloxacin 2000 ·Drugs of today ·Pamela Moise, Mary C. Birmingham, J J Schentag	50
20	The radial tunnel syndrome 1994 ·International Orthopaedics ·(unknown), Pamela Moise	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact